Real-life impact of cefiderocol in carbapenem-resistant Acinetobacter baumannii infections (CRAb): a narrative review Francesco FerraraLorenzo MartelloneGiacomo Polito Review 12 June 2025
The efficacy and safety of PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone in advanced or metastatic gastric or gastroesophageal junction cancer: a meta-analysis of randomized controlled trials Hu PiaoLi WenpingMao Shumei Review 10 June 2025
17th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT) Abstracts 10 June 2025
Comment on: “Genome-wide association study of direct oral anticoagulants and their relation to bleeding” Muhammad Umar Farooque KhosoMuhammad Hammad CholaMuhammad Hasan Correspondence 07 June 2025
Comparative efficacy and adverse effects of β3-agonists and antimuscarinics in overactive bladder: a network and component network meta-analysis Wenlin HuangXueqin ZhengYong Xu Research 07 June 2025
Literature-based case analysis of serious adverse drug events associated with edoxaban Xuanyu LuanDongyang ZhouQingxia Zhang Research 07 June 2025
Pharmacogenomics-guided treatment versus conventional treatment in patients with Schizophrenia: Evaluation of medication adherence and switching rate Jiaqi WangYuhang YanChunhua Zhou Research 06 June 2025
Disproportionality analysis of serotonin syndrome associated with selective serotonin reuptake inhibitors: a pharmacovigilance analysis Taelim ChoiJeongseon OhDong Keon Yon Research 06 June 2025
Signal detection between 5-alpha reductase inhibitors and the risk of suicidality and depression: an international pharmacovigilance analysis Soyun LeeHyesu JoDong Keon Yon Research 06 June 2025
Global burden of vaccine-associated Raynaud’s phenomenon, 1968–2024: A comprehensive analysis of the pharmacovigilance database Jinyoung JeongHyunjee KimDong Keon Yon Research 06 June 2025
Tranexamic acid-induced anaphylaxis: a systematic review Pei-shuang LinYun-tai YaoDaniel I. Sessler Review 02 June 2025
Attitudes, barriers, and facilitators toward tools supporting appropriate prescribing among healthcare professionals: a cross-sectional study Monia DonatiValentina GiunchiElisabetta Poluzzi Research Open access 31 May 2025
Tegoprazan: a novel, highly selective, and potent potassium-competitive acid blocker (P-CAB) Wenlu WangHafiza Sidra YaseenJannat Bibi Review 29 May 2025
Association between antidepressant use and gynecological cancer risk: a systematic review and meta-analysis Francisco Cezar Aquino de MoraesPedro Henrique de Souza WagnerRommel Mario Rodríguez Burbano Research 29 May 2025
Signal detection of ferric carboxymaltose-induced serious adverse events: disproportionality analysis of FAERS and VigiBase data and systematic review of case reports Reddikumar Reddy GaliguttaChristy ThomasKrishna Undela Research 22 May 2025 Pages: 1081 - 1096
Purine xanthine oxidase inhibitors are not conducive to the prognosis of chronic heart failure: a meta-analysis Lin YeAnyi XuFang Wang Research 10 May 2025 Pages: 1069 - 1079
Antithrombotic therapy for secondary stroke prevention in patients with cancer: a systematic review and network meta-analysis Leonardo Zumerkorn PipekRafaela Farias Vidigal NascimentoGuilherme Diogo Silva Review 07 May 2025 Pages: 1001 - 1015
Pentoxifylline uses in inner ear diseases Ahmed RamziSubhia MayaMostafa Ramzi Shiha Review 07 May 2025 Pages: 955 - 999
Drug-eluting stent versus bare metal stent for symptomatic intracranial stenosis: a comparative systematic review and meta-analysis study Mohammad Sina MirjaniPouria DelbariHamidreza Saber Review 06 May 2025 Pages: 939 - 954
The drug-drug interaction between dolutegravir and magnesium: not all salts are the same Dario CattaneoAnna Lisa RidolfoCristina Gervasoni Correspondence 05 May 2025 Pages: 1097 - 1098
Establishment of a visualization platform for ADR query and analysis: an example of severe skin adverse reactions caused by sulfonylureas Hui-Min YuYa-Min HuangXin-qiong Huang Research 29 April 2025 Pages: 1055 - 1067
Exploring risk assessment tools for medicine-related problems among culturally and linguistically diverse patients in Australia: a systematic review Rawan SawalhaSarah Al-SamawyBeata Bajorek Review 28 April 2025 Pages: 913 - 938
Signals from randomized clinical trials predicting hepatotoxicity of flupirtine: systematic review Mahir FidahicEmilija Lozo VukovacLivia Puljak Research 23 April 2025 Pages: 1043 - 1054
Post-market safety profile and suicide/self-injury risk signals of dextromethorphan/bupropion: a real-world pharmacovigilance study Lingjing YuanJianping HeXiangyu Li Research 22 April 2025 Pages: 1029 - 1041
Analysis of a medication discrepancy management platform in reducing medication discrepancy and influencing factors among elderly patients with polypharmacy Jingyan SongJie HuangQinghua Zhao Research 17 April 2025 Pages: 1017 - 1027
Letter to the editor: Relevant errors in a systematic review and network meta-analysis evaluating the efficacy and safety of different pharmacological interventions in the treatment of tardive dyskinesia Christoph U. CorrellDavid RoweMarco Solmi Commentary Open access 15 April 2025 Pages: 1099 - 1101
Correction to: Effectiveness of Macrolides as Add-On Therapy to Beta-Lactams in Community-Acquired Pneumonia: A Meta-Analysis of Randomized Controlled Trials Vitória Martins PrizãoOtavio Cosendey MartinsMariana de Moura Souza Correction 10 April 2025 Pages: 911 - 912
Gambling disorders and drugs: a disproportionality analysis in the WHO pharmacovigilance database Jean-Louis Montastruc Correspondence 10 April 2025 Pages: 907 - 909
Drug-related falls: proportion and impact of hospitalizations in geriatric departments on the prescription of fall-risk increasing drugs (FRIDs) Céline VaeskenVéronique Lelong-BoulouardAlexandre Meurant Research 10 April 2025 Pages: 885 - 893
Generative AI vs. human expertise: a comparative analysis of case-based rational pharmacotherapy question generation Muhammed Cihan GüvelYavuz Selim KıyakCanan Uluoğlu Research 09 April 2025 Pages: 875 - 883
Efficacy of cyclophosphamide for skin fibrosis in systemic sclerosis: a systematic review and single-arm meta-analysis Xin TianPengJiao AnBo Zhang Research 08 April 2025 Pages: 863 - 874
A novel physiologically-based pharmacokinetic model to estimate reduced CYP3A4 activity in cancer patients utilizing the neutrophil-to-lymphocyte ratio as an inflammatory marker David E. CoutantJessica RehmelStephen D. Hall Research 05 April 2025 Pages: 853 - 862
Predictive Role of Serotonin Receptor (5HTR2A) and Dopamine Receptor (DRD2) gene polymorphisms in risperidone-induced weight gain and hyperprolactinemia in patients with schizophrenia Alladi Charanraj GoudRavi Philip RajkumarSuresh Kumar Srinivasamurthy Correspondence 02 April 2025 Pages: 899 - 905
Efficacy and safety of pembrolizumab in the treatment of advanced hepatocellular carcinoma: a systematic review and meta-analysis Mingyang TangTao LiuJun Ding Review 02 April 2025 Pages: 815 - 830
Effect of dapagliflozin on malignant ventricular arrhythmias in elderly after acute myocardial infarction: a propensity score-matched cohort study Li DengJingyi WangLing Sun Research 01 April 2025 Pages: 839 - 851
Effects of oral antidiabetic agents on the renin–angiotensin–aldosterone system Xifeng YangYijie QiYunfeng Liu Review 01 April 2025 Pages: 801 - 813
Psychotropic polypharmacy impairs walking independence in post-stroke patients Ayaka MatsumotoYoshihiro YoshimuraKouki Yoneda Research 31 March 2025 Pages: 831 - 838
Reply to correspondence Omar IsmailKaram AlbdourAmeen Alsaras Correspondence 25 March 2025 Pages: 895 - 897
Exploring the comprehensive factors influencing tacrolimus pharmacokinetics in early renal transplant recipients: A population pharmacokinetic analysis Yan ZhangLing XueLiyan Miao Research 24 March 2025 Pages: 785 - 799
Genome-wide association study of direct oral anticoagulants and their relation to bleeding Sofia AttelindNiclas ErikssonPär Hallberg Research Open access 21 March 2025 Pages: 771 - 783
Influence of cigarette smoking on drugs’ metabolism and effects: a systematic review Stefano ZanniJole Del PreteCarmela Protano Review Open access 20 March 2025 Pages: 667 - 695
Unveiling cardiovascular and respiratory toxicities with monoclonal antibodies in multiple myeloma: disproportionality analysis from the FDA Adverse Event Reporting System Maria Antonietta BarbieriGiulia RussoEdoardo Spina Research 17 March 2025 Pages: 755 - 770
Facilitators and barriers to generic and biosimilar medications in the Middle East and North Africa: insights from physicians and pharmacists—a systematic review Kefah Ali AlqawasmehThomas MasonRania Al Dweik Review Open access 14 March 2025 Pages: 647 - 665
Prescribing patterns of glucagon-like peptide-1 receptor agonists in the Swedish capital region—a register-based cross-sectional study Alice ForsTomas ForslundBjörn Wettermark Research Open access 13 March 2025 Pages: 739 - 753
Evaluation of surrogate endpoints in phase III randomized control trials of advanced hepatocellular carcinoma treated with immune checkpoint inhibitors Ke JiangMiaowen LiuZhenwei Peng Research 13 March 2025 Pages: 727 - 737
A narrative review of the placebo effect: historical roots, current applications, and emerging insights Cagri OzpolatYagmur OkcayOğuzhan Yildiz Review 13 March 2025 Pages: 625 - 645
Era of surrogate endpoints and accelerated approvals: a comprehensive review on applicability, uncertainties, and challenges from regulatory, payer, and patient perspectives Rohini SharmaAnamika GulatiKanwaljit Chopra Review 13 March 2025 Pages: 605 - 623
The effect of colchicine on coagulation in patients with chronic coronary disease who use vitamin K antagonists Jeroen P. A. HouwenArief LalmohamedArend Mosterd Research Open access 07 March 2025 Pages: 719 - 725
Unravelling the implementation of pharmacogenetic testing in Belgium Jolyce BourgeoisElena CostaFrank Hulstaert Research 28 February 2025 Pages: 711 - 718
Clinical pharmacology—how it shapes the drug development journey Matthias KruseSimona StankeviciuteSheryl Perry Perspective Open access 26 February 2025 Pages: 597 - 604
